Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer
by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18
Updated on: January 30,2024
13
Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer
by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18
Updated on:January 30,2024
13
